Engineered clotting protein stops bleeding in most common inherited bleeding disorder

The first protein engineered to help control bleeding episodes in patients with severe von Willebrand disease (vW disease) has been shown to be safe and effective, according to results of a Phase III trial.

from Today's Healthcare News -- ScienceDaily http://ift.tt/1E9srxa